Bio-Rad Laboratories Inc (BIO) Shares Fall 5.9% -- What GF Score of 73 Tells Investors
gurufocus.com · 2026-10-01
On October 01, 2026, Bio-Rad Laboratories Inc (BIO) shares fell 5.9% to a current price of $355.57. The stock has traded in a 52-week range of $236.73 to $396.2
TickrTrends take: Bio-Rad Laboratories shares experienced a recent decline, which occurs against TickrTrends' current assessment that the stock trades at an overvalued level within the Healthcare sector. The company's GF Score of 73 suggests moderate fundamental quality, a metric that investors focused on valuation should weigh against the premium pricing TickrTrends has identified. For valuation-conscious investors, this combination of elevated price levels and a mid-range quality score represents a key tension point to monitor as the stock moves forward.
Read the full story at gurufocus.com →
Is BIO undervalued? See TickrTrends' fair value analysis →